These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15368800)

  • 1. The relationship between preprocedural platelet size and subsequent in-stent restenosis.
    Norgaz T; Hobikoglu G; Aksu H; Bolca O; Uyarel H; Eren M; Narin A
    Acta Cardiol; 2004 Aug; 59(4):391-5. PubMed ID: 15368800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
    Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation.
    Hahn JY; Kim HS; Koo BK; Na SH; Chung JW; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
    Int J Cardiol; 2006 May; 109(2):267-9. PubMed ID: 16644391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
    Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
    Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
    Turak O; Ozcan F; Isleyen A; Tok D; Sokmen E; Buyukkaya E; Aydogdu S; Akpek M; Kaya MG
    Am J Cardiol; 2012 Nov; 110(10):1405-10. PubMed ID: 22858185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.
    Gabbasov Z; Kozlov S; Byazrova S; Saburova O; Melnikov I; Caprnda M; Curilla E; Gaspar L; Kruzliak P; Smirnov V
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):898-905. PubMed ID: 27637207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris.
    Geng N; Su G; Wang S; Zou D; Pang W; Sun Y
    BMC Cardiovasc Disord; 2019 Jul; 19(1):175. PubMed ID: 31340761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
    Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
    Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
    Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
    Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis.
    Canpolat U; Turak O; Özcan F; Öksüz F; Mendi MA; Yayla Ç; Aydoğdu S
    Arch Endocrinol Metab; 2017; 61(2):130-136. PubMed ID: 28489156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
    Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
    Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation.
    Niroomand F; Hauer O; Tiefenbacher CP; Katus HA; Kuebler W
    Heart; 2004 Oct; 90(10):1189-93. PubMed ID: 15367521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.